Cyclophosphamide in dermatology. - Wikidata - wikimedia - TriplyDB

Cyclophosphamide in dermatology.

Cyclophosphamide in dermatology.

http://www.wikidata.org/entity/Q38710150

about

Cloning, expression and identification of KTX-Sp4, a selective Kv1.3 peptidic blocker from Scorpiops pococki.

P2860

Q47126809-5FE8F9BA-71AE-4A2B-BBC4-0A769A566901

P2860

Cyclophosphamide in dermatology.

http://www.wikidata.org/entity/Q38710150

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Cyclophosphamide in dermatology.

@en

type

label

Cyclophosphamide in dermatology.

@en

prefLabel

Cyclophosphamide in dermatology.

@en

P1433

Q38710150-BC1B82CA-C364-4FE6-8847-DB644B8F5F27

P1476

Q38710150-A9C9376C-A913-40F5-839D-DDA9B3B6AD0D

P2093

Q38710150-3509998A-4B72-431E-AFA9-EF817E77DC93

Q38710150-C1EC3645-29BC-47DE-863F-4CE0CA520DC7

P2860

Q38710150-035D4AF4-2FC5-49E5-B450-5969CB260D3C

Q38710150-04BB12A7-3CD1-4661-B788-8D4AD5850BD9

Q38710150-06BE8DC8-07EC-4369-A7ED-74F2EADAA9BE

Q38710150-078FCB32-26DE-4DDB-9CCB-D41BAA1CBEF7

Q38710150-0C1A4566-AE41-41F4-B7BA-86CD89F84D5D

Q38710150-0C35806F-4E2F-4F36-8811-1A82777FC53A

Q38710150-110C813D-4DE7-41F7-9506-70A1E5BCDDE2

Q38710150-1B163C11-5FA0-4307-891A-234A9E87D7E3

Q38710150-235E7888-0B93-4737-8E48-345C07BDFE59

Q38710150-28F6F185-E9A0-450F-A4A0-FBBA817647A1

P304

Q38710150-EEA229E6-634E-478A-B517-77468FE5F986

P31

Q38710150-AAF3D0BA-CD60-48DA-A612-373D78E92255

P356

Q38710150-1F7610BC-3537-4F3B-A5DD-DD476743BB82

P433

Q38710150-C97F2E8B-10F4-410D-B717-20303AE29883

P478

Q38710150-23E75F89-C123-4908-B720-0FE58732693B

P577

Q38710150-1A3B6E1F-039F-4831-B9DA-710F45DF928B

P698

Q38710150-0A318684-1B76-485B-9344-7EF3A6895FF6

P356

P1433

Australasian Journal of Dermatology

P1476

Cyclophosphamide in dermatology.

@en

P2093

Janet Kim

http://www.w3.org/2001/XMLSchema#string

Jonathan J Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial

Interventions for pemphigus vulgaris and pemphigus foliaceus

Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions

Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.

Generalized eruptive keratoacanthoma of Grzybowski: response to cyclophosphamide.

Cytophagic histiocytic panniculitis: a report of four cases.

Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.

P304

5-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJD.12406

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26806212

http://www.w3.org/2001/XMLSchema#string